References
1.
Fields W, Maslenikov V, Meyer J, Hass W, Remington R, Macdonald M: Joint study of extracranial arterial occlusion. JAMA 1970; 211:1993–2003.
2.
Shaw D, Venables G, Cartlidge N, Bates D, Dickinson P: Carotid endarterectomy in patients with transient cerebral ischemia. J Neurol Sci 1984;64:45–53.
3.
CASANOVA Study Group: Carotid surgery versus medical therapy in asymptomatic carotid stenosis. Stroke 1991;22:1229–1235.
4.
Mayo Asymptomatic Carotid Endarterectomy Study Group: Results of a randomized controlled trial of carotid endarterectomy for asymptomatic carotid stenosis. Mayo Clin Proc 19923;67:513–518.
5.
Hobson IR, Weiss D, Fields W, Goldstone J, Moore W, Towne J, et al: Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. N Engl J Med 1993;328:221–227.
6.
European Carotid Surgery Trialists’ Group: Randomised trial of endarterectomy for recently symptomatic carotid stenosis: Final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998;351:1379–1387.
7.
Barnett HJM, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, et al: Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med 1998;339:1415–1425.
8.
Taylor DW, Barnett HJM, Haynes RB, et al, for the ASA and Carotid Endarterectomy (ACE) Trial Collaborators: Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: A randomized controlled trial. Lancet 1999;353:2179–2184.
9.
North American Symptomatic Carotid Endarterectomy Trial Collaborators: Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade stenosis. N Engl J Med 1991;325:445–453.
10.
Barnett HJM, Eliasziw M, Meldrum HE: Prevention of ischemic stroke. BMJ 1999;318:1539–1543, Erratum BMJ 1999;319:626.
11.
Kappelle LJ, Eliasziw M, Fox AJ, Sharpe, Barnett HJM, for the North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group: Importance of intracranial atherosclerotic disease in patients with symptomatic stenosis of the internal carotid artery. Stroke 1999;30:282–286.
12.
Ferguson GG, Eliasziw M, Barr HWK, Clagett GP, Barnes RW, Wallace MC, Taylor DW, Haynes RB, Finan JW, Hachinski VC, Barnett HJM, for the North American Symptomatic Carotid Endarterectomy Trial (NASCET) Collaborators: The North American Symptomatic Carotid Endarterectomy Trial: Surgical results in 1415 patients. Stroke 1999;30:1751–1758.
13.
Henderson RD, Eliasziw M, Fox AJ, Rothwell PM, Barnett HJM, for the North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group: Angiographically-defined collateral circulation and the risk of stroke in patients with severe carotid artery stenosis. Stroke 2000;31:128–132.
14.
Barnett HJM, Gunton RW, Eliasziw M, Fleming L, Sharpe B, Gates P, Meldrum H, for the North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group: The causes and severity of ischemic stroke in patients with internal carotid artery stenosis. JAMA 2000;283:1429–1436.
15.
Inzitari D, Eliasziw M, Sharpe BL, Fox AJ, Barnett HJM, for the North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group: Risk factors and outcome of patients with carotid artery stenosis presenting with lacunar stroke. Neurology 2000;54:660–666.
16.
Executive Committee for the Asymptomatic Carotid Atherosclerosis Study: Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995;273:1421–1428.
17.
Hertzer NR, O’Hara PJ, Mascha EJ, Krajewski LP, Sullivan TM, Beven EG: Early outcome assessment for 2228 consecutive carotid endarterectomy procedures: The Cleveland Clinic experience from 1989 to 1995. J Vasc Surg 1997;26:1–10.
18.
Wong JH, Findlay JM, Suarez-Almazor ME: Regional performance of carotid endarterectomy. Appropriateness, outcomes and risk factors for complications. Stroke 1997;28:891–898.
19.
Kucey DS, Bowyer B, Iron K, Austin P, Anderson G, Tu JV: Determinants of outcome after carotid endarterectomy. J Vasc Surg 1998;28:1051–1058.
20.
Halliday AW, Thomas D, Mansfield A: The Asymptomatic Carotid Surgery Trial (ACST). Rationale and design. Eur J Vasc Surg 1994;8:703–710.
21.
Nicolaides AN: Asymptomatic carotid stenosis and risk of stroke. Identification of a high risk group (ACSRS). A natural history study. Int Angiol 1995;14:21–23.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the...
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
